Optimal dose and safety of molnupiravir in patients with early SARS

molnupiravir dose  dose of molnupiravir Recommend interrupting breastfeeding or pumping and discarding breast milk during treatment and for four days after Two oral drugs, molnupiravir and paxlovid , provide equivalent therapeutic benefit in preventing severe COVID-19 in

Molnupiravir should be started as soon as possible after a diagnosis of symptomatic COVID-19 has been made and within five days of symptom onset Missed doses – No renal dose adjustment Dosing: Antimicrobial Dosing in Intermittent & Continuous Hemodialysis Indication Intermittent Hemodialysis Continuous Hemodialysis

Usual dose: 800 mgtime, orally x 2 timesday, duration of treatment: 5 days Molnupiravir is used after eating, the patient should pay attention to take the Double doses should not be taken to compensate for missed doses DOSE To date, no drug interactions with molnupiravir have been identified The